6,915
Participants
Start Date
January 31, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2018
Phase I
Chemotherapy, ITK, Hormotherapy, Immunotherapy
Insitut Bergonié, Bordeaux
Lead Sponsor
Institut Bergonié
OTHER